Therefore, results of our present study first reveal that the interaction between carcinoma and immune cells could alter the expression of immune checkpoint‐related molecules in both carcinoma and immune cells, such as PD‐L1, PD‐1, and B7‐1. This evidence concerns the gene PDCD1 and carcinoma.